|
Q3 FY2026
As of Sep 30, 2026
|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
|
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets: | ||||||||||
| Cash and cash equivalents | ||||||||||
| Short-term investments | ||||||||||
| Accounts receivable (including related party amounts of $569 and $569, respectively) | ||||||||||
| Other receivables (including related party amounts of $0 and $61, respectively) | ||||||||||
| Prepaid expenses and other current assets | ||||||||||
| Total current assets | ||||||||||
| Restricted cash | ||||||||||
| Property and equipment, net | ||||||||||
| Operating lease right-of-use assets | ||||||||||
| Financing lease right-of-use asset | ||||||||||
| Long-term investments | ||||||||||
| Deferred offering costs | ||||||||||
| Other long-term assets | ||||||||||
| Total assets | ||||||||||
| Liabilities, convertible preferred stock, and stockholders' equity (deficit) | ||||||||||
| Current liabilities: | ||||||||||
| Accounts payable | ||||||||||
| Accrued expenses (including related party amounts of $35 and $0, respectively) | ||||||||||
| Current portion of operating lease liabilities | ||||||||||
| Current portion of financing lease liability | ||||||||||
| Other current liabilities | ||||||||||
| Total current liabilities | ||||||||||
| Operating lease liabilities, net of current portion | ||||||||||
| Financing lease liability, net of current portion | ||||||||||
| Simple agreements for future equity ("SAFEs") (including related party amounts of $0 and $20,315, respectively) | ||||||||||
| Other non-current liabilities | ||||||||||
| Total liabilities | ||||||||||
| Convertible preferred stock | ||||||||||
| Series A convertible preferred stock | ||||||||||
| Series B convertible preferred stock | ||||||||||
| Stockholders' equity : | ||||||||||
| Common stock, $0.0001 par value; 700,000,000 shares authorized at September 30, 2026 and December 31, 2025; 49,265,258 and 24,595,550 shares issued and outstanding at September 30, 2026 and December 31, 2025 respectively | ||||||||||
| Additional paid-in capital | ||||||||||
| Accumulated other comprehensive (loss) income | ||||||||||
| Accumulated deficit | ||||||||||
| Total stockholders' equity | ||||||||||
| Total liabilities and stockholders' equity |
Loading...